Therapeutic targeting of childhood medulloblastoma
1 Mga view
• 07/06/23
0
0
I-embed
administrator
Mga subscriber
Dr Singh speaks with ecancertv at NCRI 2016 about the pathways through which cancer stem cells drive tumourigenesis and subvert treatments, in the specific setting of medulloblastoma.
She describes research with patient-derived xenograft models to modify treatment regimens, giving insight into opportunities to avoid the systemic toxicities associated with current therapies.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento